Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
Hildebrandt
P
P
D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000191:economics* / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic
D007328:Insulin